Stockscreener 앱 받기
42.25
1.83%
0.76
Viking Therapeutics Inc 주식(VKTX)의 최신 뉴스
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck? - MSN
Down 18% in 1 Day, Is Viking Therapeutics Stock in Trouble Due to Merck? - The Motley Fool
Why Viking Therapeutics (VKTX) Stock is Down Today - GuruFocus.com
Why Viking Therapeutics Tumbled by More Than 10% This Week - MSN
Viking Therapeutics, Inc. (VKTX) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Why Novo Nordisk Stock Got Destroyed Today, but Eli Lilly and Viking Stocks Are Up - sharewise
Viking Therapeutics (NASDAQ:VKTX) Trading 4.8% HigherStill a Buy? - MarketBeat
Looking Into Viking Therapeutics's Recent Short Interest - Benzinga
Viking Therapeutics (VKTX) Sees Surge Amid Novo Nordisk Clinical Trial Results - GuruFocus.com
Viking Therapeutics (NASDAQ:VKTX) Shares Gap UpTime to Buy? - MarketBeat
Viking Therapeutics stock surges 12% amid Novo Nordisk trial woes By Investing.com - Investing.com Canada
Here's Why VKTX Stock Plummeted 18% on Wednesday - MSN
Viking Therapeutics (NASDAQ:VKTX) Trading Up 7.2%Time to Buy? - MarketBeat
Viking Therapeutics: Competition Fears Are Exaggerated (NASDAQ:VKTX) - Seeking Alpha
Viking Therapeutics: Holiday Gift (NASDAQ:VKTX) - Seeking Alpha
Companies Like Viking Therapeutics (NASDAQ:VKTX) Can Afford To Invest In Growth - Yahoo Finance
MML Investors Services LLC Increases Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Sold by XTX Topco Ltd - MarketBeat
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs - AOL
Viking Therapeutics Stock Slides After Merck Strikes GLP-1 Deal With Chinese Biopharma, Retail Unperturbed - MSN
Viking Therapeutics (NASDAQ:VKTX) Trading Down 8.9%Should You Sell? - MarketBeat
Viking Plummets After Merck Inks A $2.01 Billion Obesity Deal — With Someone Else - Investor's Business Daily
Why Viking Therapeutics (VKTX), HEICO Corporation (HEI), and ABM Industries (ABM) Stocks Are Plunging Today? - Insider Monkey
Viking Therapeutics (NASDAQ:VKTX) Shares Gap DownWhat's Next? - MarketBeat
What's Going On With Viking Therapeutics Stock On Wednesday? - Yahoo Finance
Merck-Hansoh deal for oral GLP-1 hurts obesity drug developers - Seeking Alpha
Smart Money Is Betting Big In VKTX Options - Benzinga
HC Wainwright Reiterates Buy Rating for Viking Therapeutics (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics lower after Merck signs pact with Hansoh for GLP-1 drug - TipRanks
(VKTX) Proactive Strategies - Stock Traders Daily
Viking Therapeutics (NASDAQ:VKTX) Trading Up 0.6%Here's What Happened - MarketBeat
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On. - AOL
Is Viking Therapeutics, Inc. (VKTX) the Best Weight Loss Stock to Buy Now According to Hedge Funds? - Insider Monkey
Viking Therapeutics: Caution Ahead Of Novo's CagriSema Readout (Rating Downgrade) - Seeking Alpha
Viking Therapeutics (NASDAQ:VKTX) Trading Up 2%Still a Buy? - MarketBeat
2 Soaring Stocks That Could Climb 68% to 166% Higher in 2025, According to Wall Street - Yahoo Finance
Viking Therapeutics, Inc. (VKTX) Stock Moves -1.75%: What You Should Know - MSN
Viking Therapeutics (NASDAQ:VKTX) Trading Down 2.4%What's Next? - MarketBeat
Vestcor Inc Purchases Shares of 11,700 Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives $106.75 Average Target Price from Analysts - MarketBeat
Stifel Financial Corp Increases Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics is Now Oversold (VKTX) - Nasdaq
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 1.8%Should You Sell? - MarketBeat
Viking Therapeutics to Participate at Upcoming Investor Conferences - The Eastern Progress Online
Viking Therapeutics to Participate at Morgan Stanley 22nd Annual Global Healthcare Conference - The Eastern Progress Online
State Street Corp Reduces Stock Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Down 2.7%Time to Sell? - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Shares Up 1.8%Still a Buy? - MarketBeat
Viking Therapeutics to Participate in Upcoming Investor Conferences and Events - Marketscreener.com
The Zacks Analyst Blog Eli Lilly, Novo Nordisk's Amgen and Viking Therapeutics - Yahoo Finance
2 'Strong Buy' Biotech Stocks With 120% or More Upside Potential - MSN
Pier Capital LLC Acquires 31,908 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024 - The Eastern Progress Online
(VKTX) Long Term Investment Analysis - Stock Traders Daily
IHT Wealth Management LLC Makes New $845,000 Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Rockefeller Capital Management L.P. Has $2.15 Million Stake in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Trading 3.2% HigherWhat's Next? - MarketBeat
Viking Therapeutics, Inc. (NASDAQ:VKTX) Shares Acquired by Bank of Montreal Can - MarketBeat
Cerity Partners LLC Invests $884,000 in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Stock Price Up 1.9%Here's Why - MarketBeat
Viking Stock Pops, Then Drops On Latest Obesity/MASH Data: Why I'm Still Bullish (VKTX) - Seeking Alpha
2.88%
2.65%
자본화:
|
볼륨(24시간):